HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased cerebral iron uptake in Wilson's disease: a 52Fe-citrate PET study.

AbstractUNLABELLED:
Toxicity of abundant copper is the main cause of brain and liver tissue damage in patients with Wilson's disease (WD). However, there is also evidence of a disturbed iron metabolism in this genetically determined disorder. This PET study was undertaken to assess cerebral iron metabolism in WD patients.
METHODS:
We used 52Fe-citrate, which converts to 52Fe-transferrin in blood plasma, to study basic pharmacokinetic features of the cerebral iron transport in 6 WD patients and in 16 healthy volunteers (control subjects). A 2-tissue-compartment model and multiple time graphic plotting were used to calculate 52Fe-transferrin distribution volumes and transport rates.
RESULTS:
Net iron uptake (Ki) from plasma into brain tissue was significantly (P < 0.001) higher in WD patients (Ki [mean +/- SEM] = 15.1E-05 +/- 7.13E-05 [1/min]) than in healthy volunteers (Ki = 2.66E-05 +/- 0.351E-05 [1/min]). There was no difference of tracer iron distribution in the cerebral plasma volume between patients and healthy volunteers. Iron uptake values resulting from 2 methods to model PET data of patients and healthy volunteers were highly correlated (P < 0.001).
CONCLUSION:
An abnormally increased cerebral 52Fe-transferrin uptake was found in WD patients.
AuthorsM Bruehlmeier, K L Leenders, P Vontobel, C Calonder, A Antonini, A Weindl
JournalJournal of nuclear medicine : official publication, Society of Nuclear Medicine (J Nucl Med) Vol. 41 Issue 5 Pg. 781-7 (May 2000) ISSN: 0161-5505 [Print] United States
PMID10809192 (Publication Type: Journal Article)
Chemical References
  • Ferric Compounds
  • Iron Radioisotopes
  • Radiopharmaceuticals
  • Transferrin
  • ferric citrate
  • Copper
  • Iron
Topics
  • Adult
  • Aged
  • Brain (diagnostic imaging, metabolism)
  • Copper (blood)
  • Female
  • Ferric Compounds
  • Hepatolenticular Degeneration (diagnostic imaging, metabolism)
  • Humans
  • Iron (metabolism)
  • Iron Radioisotopes
  • Male
  • Middle Aged
  • Radiopharmaceuticals
  • Tomography, Emission-Computed
  • Transferrin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: